Buy Overview of B7-33 Pre-Mixed Peptide In Europe

`Buy B7-33 Pre-Mixed Peptide in Europe and skip the reconstitution work. This ready-to-use B7-33 liquid peptide is a relaxin analogue formulated for researchers studying tissue repair, fibrosis reduction, and cardiac remodeling.

No mixing. No guesswork. Just pre-mixed B7-33 peptide delivered cold-chain from our EU warehouse with full COA verification. Labs across the UK, Germany, France and the EU use this B7-33 pre-mixed solution to maintain consistency in anti-fibrotic and wound healing research.

Ideal for in-vitro and cellular studies on collagen remodeling, cardiovascular function, and regenerative pathways. In stock now and ships in 48 hours.`

B7-33 Pre-Mixed Peptide is a ready-to-use formulation containing B7-33, an investigational synthetic peptide derived from the B-chain of the naturally occurring hormone human relaxin-2 (H2 relaxin). B7-33 was developed to selectively activate the Relaxin Family Peptide Receptor 1 (RXFP1) while retaining many of relaxin’s anti-fibrotic properties in preclinical studies. (PubMed Central (PMC))

Unlike lyophilized peptide products that require reconstitution before use, a pre-mixed formulation is supplied in solution according to the manufacturer’s specifications. Although B7-33 has shown encouraging results in laboratory and animal models, it remains an investigational compound and has not been approved by major regulatory authorities for routine medical use.  tissue repair research peptide Europe

What Is B7-33 Pre-Mixed Peptide?

B7-33 Pre-Mixed Peptide is a manufacturer-prepared liquid formulation intended for research or other manufacturer-specified applications. The peptide is supplied in a ready-to-use format that eliminates the need for reconstitution before handling.

Common characteristics include:

• Ready-to-use liquid formulation
• Synthetic relaxin-2 analogue
• Manufacturer-labeled concentration
• Quality-controlled manufacturing
• Sterile packaging where applicable
• Batch and lot identification
• Available in different vial sizes depending on the manufacturer

Features of B7-33 Pre-Mixed Peptide

Key product features may include:

• Pre-mixed formulation for convenience
• Clearly labeled peptide concentration
• Secure vial packaging
• Consistent manufacturing standards
• Product traceability through batch identification
• Manufacturer-specific storage recommendations
• Available in multiple strengths depending on the supplier

Research Background of B7-33 Pre-Mixed Peptide

B7-33 was engineered as a simplified single-chain analogue of human relaxin-2 to activate the RXFP1 receptor while exhibiting selective signaling properties. In laboratory and animal studies, researchers have investigated its role in reducing fibrosis and supporting tissue remodeling in organs such as the heart, lungs, and kidneys. (PubMed Central (PMC))

Preclinical research suggests that B7-33 may promote anti-fibrotic signaling through pathways involving extracellular matrix remodeling while avoiding some signaling pathways associated with full-length relaxin. However, these findings are based primarily on experimental models, and additional clinical research is needed to establish its safety and effectiveness in humans. (PubMed 

Potential Research Applications of B7-33 Pre-Mixed Peptide

Published research has explored B7-33 in areas including:

• Fibrosis research
• Cardiovascular biology
• Pulmonary fibrosis studies
• Kidney fibrosis research
• Tissue remodeling
• Extracellular matrix biology
• Laboratory and scientific investigations

These applications remain investigational and should not be interpreted as approved medical uses.

Storage Guidelines for B7-33 Pre-Mixed Peptide

To help maintain product quality:

• Store according to the manufacturer’s recommendations.
• Keep the vial in its original packaging.
• Protect from excessive heat and direct sunlight.
• Refrigerate if recommended by the manufacturer.
• Do not use if the container is damaged or leaking.
• Keep out of the reach of children.

Always follow the storage instructions provided on the product label.

Safety Information for B7-33 Pre-Mixed Peptide

Important precautions include:

• Use only according to the manufacturer’s labeling.
• Handle using appropriate laboratory procedures.
• Do not use if the seal has been broken or the product appears contaminated.
• Follow all recommended storage conditions.
• Consult qualified professionals regarding appropriate handling.

B7-33 remains an investigational compound, and its safety and effectiveness for routine therapeutic use have not been established by major regulatory authorities.

Disposal of B7-33 Pre-Mixed Peptide

After use or when expired:

• Dispose of the product according to local regulations.
• Do not reuse single-use containers.
• Discard damaged or expired vials appropriately.
• Follow institutional procedures for laboratory or pharmaceutical waste disposal.

Frequently Asked Questions About B7-33 Pre-Mixed Peptide

What is B7-33 Pre-Mixed Peptide?

B7-33 Pre-Mixed Peptide is a ready-to-use formulation containing B7-33, an investigational synthetic peptide derived from human relaxin-2 for research purposes. (PubMed Central (PMC))

What is B7-33 Pre-Mixed Peptide used for?

B7-33 Pre-Mixed Peptide is intended for laboratory research or other manufacturer-specified applications. Current research has focused on fibrosis, tissue remodeling, and cardiovascular biology, but it is not approved for routine medical treatment.

How should B7-33 Pre-Mixed Peptide be stored?

B7-33 Pre-Mixed Peptide should be stored according to the manufacturer’s recommendations, which may include refrigeration and protection from excessive heat, moisture, and direct sunlight. (Peptide Database)

ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY.

DISCLAIMER: Products are supplied for research purposes only and are not intended to diagnose, treat, cure, or prevent any disease.